Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 6 September 2011, its broker Davy purchased 104,581 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.2129 per share.

The 104,581 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 239,617,507 to 239,512,926. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 7 September 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720